Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 35.1B |
| Enterprise Value | 34.14B |
| P/E Ratio | 32.06 |
| PEG Ratio | -0.42 |
| Price/Sales Ratio | 4.27 |
| Price/Book Ratio | 4.58 |
| Enterprise/Revenue | 3.77 |
| Enterprise/EBITDA | 16.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.18 |
| Operating Margin | 0.18 |
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
| Revenue | 4.92B |
| Revenue/Share | 6.13 |
| Gross Profit | 3.64B |
| EBITDA | 2.61B |
| Net Income | 2.13B |
| Diluted EPS | 2.77 |
| Total Cash | 3.53B |
| Total Cash/Share | 4.59 |
| Total Debt | 98.34M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.38 |
| Book Value Per Share | 7.81 |
| 52-Week Change | -23.52 |
| 52-Week High | 50.95 |
| 52-Week Low | 34.7 |
| Moving Average 50 Days | 37.77 |
| Moving Average 200 Days | 42.11 |
| Average Volume | 4.13M |
| Shares Outstanding | 570.09M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 2.34 |
| Trailing Annual Dividend Yield | 6.62 |
| Payout Ratio | 2.21 |
| Last Split Factor | 2:1 |
| Last Split Date | July 05, 2010 |